• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Background Sodium‐glucose co‐transporter (SGLT) inhibitors reduce cardiovascular
outcomes including mortality in several populations; however, their effect on atrial …

The development of non-invasive biosensor for monitoring glucose in interstitial fluid (ISF) is
still challenging, because ISF extraction through classical reverse iontophoresis (RI) is …

The prevalence of obesity and atrial fibrillation (AF), which are inextricably linked, is rapidly
increasing worldwide. Obesity rates are higher among patients with AF than healthy …

The study of the relationship between type 2 diabetes mellitus (T2DM) disease and other
pathologies (comorbidities), together with patient age variation, poses a challenge for …

Atrial fibrillation (AF) and diabetes mellitus (DM) constitute two major closely inter-related
chronic cardiovascular disorders whose concurrent prevalence rates are steadily increasing …

Atrial fibrillation/flutter (AF/AFL) is a common cardiac arrhythmia in patients with diabetes
and is associated with an increased risk of morbidity, including ischaemic stroke and heart …

Aim To evaluate the associations between metabolically healthy obesity (MHO) and different
types of incident cardiovascular events in a contemporary population. Materials and …

An increasing number of individuals are at high risk of type 2 diabetes (T2D) and its
cardiovascular complications, including heart failure (HF), chronic kidney disease (CKD) …

Introduction A growing body of evidence suggests that diabetes mellitus (DM) is associated
with an increased risk of new-onset atrial fibrillation (AF) and contributes to suboptimal …